These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 36802345)
1. CT Radiomics for Predicting Pathological Complete Response of Axillary Lymph Nodes in Breast Cancer After Neoadjuvant Chemotherapy: A Prospective Study. Li YL; Wang LZ; Shi QL; He YJ; Li JF; Zhu HT; Wang TF; Li XT; Fan ZQ; Ouyang T; Sun YS Oncologist; 2023 Apr; 28(4):e183-e190. PubMed ID: 36802345 [TBL] [Abstract][Full Text] [Related]
2. The use of longitudinal CT-based radiomics and clinicopathological features predicts the pathological complete response of metastasized axillary lymph nodes in breast cancer. Wang J; Tian C; Zheng BJ; Zhang J; Jiao DC; Qu JR; Liu ZZ BMC Cancer; 2024 May; 24(1):549. PubMed ID: 38693523 [TBL] [Abstract][Full Text] [Related]
3. Prediction of Residual Axillary Nodal Metastasis Following Neoadjuvant Chemotherapy for Breast Cancer: Radiomics Analysis Based on Chest Computed Tomography. Lee HJ; Nguyen AT; Song MW; Lee JE; Park SB; Jeong WG; Park MH; Lee JS; Park I; Lim HS Korean J Radiol; 2023 Jun; 24(6):498-511. PubMed ID: 37271204 [TBL] [Abstract][Full Text] [Related]
4. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study. Gu J; Tong T; Xu D; Cheng F; Fang C; He C; Wang J; Wang B; Yang X; Wang K; Tian J; Jiang T Cancer; 2023 Feb; 129(3):356-366. PubMed ID: 36401611 [TBL] [Abstract][Full Text] [Related]
5. Prediction of breast cancer and axillary positive-node response to neoadjuvant chemotherapy based on multi-parametric magnetic resonance imaging radiomics models. Lin Y; Wang J; Li M; Zhou C; Hu Y; Wang M; Zhang X Breast; 2024 Aug; 76():103737. PubMed ID: 38696854 [TBL] [Abstract][Full Text] [Related]
6. Computed tomography reconstruction for evaluating response in axillary lymph nodes of breast cancer after neoadjuvant chemotherapy. Wang L; Li Y; Li J; Wang T; Xie Y; He Y; Fan Z; Ouyang T Clin Transl Oncol; 2021 Feb; 23(2):240-245. PubMed ID: 32519177 [TBL] [Abstract][Full Text] [Related]
7. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients. Eun NL; Son EJ; Gweon HM; Kim JA; Youk JH Eur Radiol; 2020 Mar; 30(3):1460-1469. PubMed ID: 31802216 [TBL] [Abstract][Full Text] [Related]
8. Thin-section CT evaluation and pathologic correlation of therapeutic effect of neoadjuvant chemotherapy for axillary lymph nodes of clinically node-positive breast cancer patients. Ogawa Y; Nishioka A; Nishigawa T; Kubota K; Kariya S; Yoshida S; Tanaka Y; Moriki T; Tochika N Oncol Rep; 2003; 10(4):985-9. PubMed ID: 12792757 [TBL] [Abstract][Full Text] [Related]
9. Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer. Kim R; Chang JM; Lee HB; Lee SH; Kim SY; Kim ES; Cho N; Moon WK Radiology; 2019 Oct; 293(1):49-57. PubMed ID: 31407967 [TBL] [Abstract][Full Text] [Related]
10. A delta-radiomic lymph node model using dynamic contrast enhanced MRI for the early prediction of axillary response after neoadjuvant chemotherapy in breast cancer patients. Liu S; Du S; Gao S; Teng Y; Jin F; Zhang L BMC Cancer; 2023 Jan; 23(1):15. PubMed ID: 36604679 [TBL] [Abstract][Full Text] [Related]
11. An unsupervised learning model based on CT radiomics features accurately predicts axillary lymph node metastasis in breast cancer patients: diagnostic study. Qu L; Mei X; Yi Z; Zou Q; Zhou Q; Zhang D; Zhou M; Pei L; Long Q; Meng J; Zhang H; Chen Q; Yi W Int J Surg; 2024 Sep; 110(9):5363-5373. PubMed ID: 38847776 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study. Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259 [TBL] [Abstract][Full Text] [Related]
13. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study. Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985 [TBL] [Abstract][Full Text] [Related]
14. Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound. Zhang H; Cao W; Liu L; Meng Z; Sun N; Meng Y; Fei J J Transl Med; 2023 May; 21(1):337. PubMed ID: 37211604 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Traditional Radiomics, Deep Learning Radiomics and Fusion Methods for Axillary Lymph Node Metastasis Prediction in Breast Cancer. Li X; Yang L; Jiao X Acad Radiol; 2023 Jul; 30(7):1281-1287. PubMed ID: 36376154 [TBL] [Abstract][Full Text] [Related]
16. Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancer. Al-Hattali S; Vinnicombe SJ; Gowdh NM; Evans A; Armstrong S; Adamson D; Purdie CA; Macaskill EJ Cancer Imaging; 2019 Dec; 19(1):91. PubMed ID: 31878958 [TBL] [Abstract][Full Text] [Related]
17. A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer. Song BI Breast Cancer; 2021 May; 28(3):664-671. PubMed ID: 33454875 [TBL] [Abstract][Full Text] [Related]
18. Combining conventional ultrasound and sonoelastography to predict axillary status after neoadjuvant chemotherapy for breast cancer. Huang JX; Lin SY; Ou Y; Shi CG; Zhong Y; Wei MJ; Pei XQ Eur Radiol; 2022 Sep; 32(9):5986-5996. PubMed ID: 35364714 [TBL] [Abstract][Full Text] [Related]
19. Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissection. Baessler B; Nestler T; Pinto Dos Santos D; Paffenholz P; Zeuch V; Pfister D; Maintz D; Heidenreich A Eur Radiol; 2020 Apr; 30(4):2334-2345. PubMed ID: 31828413 [TBL] [Abstract][Full Text] [Related]
20. Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy. Koolen BB; Valdés Olmos RA; Elkhuizen PH; Vogel WV; Vrancken Peeters MJ; Rodenhuis S; Rutgers EJ Breast Cancer Res Treat; 2012 Aug; 135(1):231-40. PubMed ID: 22872522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]